US Market News
2月前
Molina Healthcare Reports First Quarter 2026 Financial ResultsApril 22, 2026 4:15 PM
Business Wire
Reaffirms Full Year 2026 Premium Revenue and Adjusted Earnings Guidance
Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2026 GAAP income per diluted share of $0.27 and adjusted income per diluted share of $2.35. Financial results are summarized below:
Three months ended
March 31,
2026
2025
(In millions, except per-share results)
Premium Revenue
$10,172
$10,628
Total Revenue
$10,796
$11,147
GAAP:
Net Income
$14
$298
EPS – Diluted
$0.27
$5.45
Medical Care Ratio (MCR)
91.1%
89.2%
G&A Ratio
7.2%
6.9%
Pre-tax Margin
0.3%
3.5%
Adjusted:
Net Income
$120
$333
EPS – Diluted
$2.35
$6.08
G&A Ratio
6.9%
6.3%
Pre-tax Margin
1.6%
3.9%
See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.
Quarter Highlights
As of March 31, 2026, the Company served approximately 5.0 million members.
Premium revenue was approximately $10.2 billion for the first quarter of 2026.
First quarter 2026 GAAP income per diluted share of $0.27 and adjusted income per diluted share of $2.35.
The Company reaffirmed its full year 2026 guidance of expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share.
“We are pleased with our first quarter results and continued disciplined approach to medical cost management,” said Joseph Zubretsky, President and Chief Executive Officer. “Medical cost trend was modestly favorable to our expectations, and our reaffirmed full year 2026 premium revenue and adjusted earnings guidance reflect a prudent view of full year results at this early point in the year. We look forward to updating you on our three-year outlook at our Investor Day event on Friday, May 8th.”
Premium Revenue
Premium revenue was approximately $10.2 billion for the first quarter of 2026, a decrease of 4% year over year. The lower premium revenue reflects the impact of lower Medicaid membership due to general market contraction and the expiration of our Medicaid contract in Virginia, and a decrease in Marketplace membership resulting from our product and pricing strategy.
Net Income
GAAP net income for the first quarter of 2026 was $0.27 per diluted share, a decrease of 95% year over year, and reflects a $93 million impairment of intangible assets related to the Company’s planned exit of the Medicare Advantage-Part D product for 2027. Adjusted net income for the first quarter of 2026 was $2.35 per diluted share, a decrease of 61% year over year.
Medical Care Ratio (MCR)
The consolidated MCR for the first quarter of 2026 was 91.1%.
The Medicaid MCR for the first quarter of 2026 was 92.0%, reflecting the January 1st rate cycle and medical cost trend that was moderately favorable to the Company’s expectations.
The Medicare MCR for the first quarter of 2026 was 89.8%, and in line with the Company’s expectation, reflecting pricing and benefit adjustments implemented for 2026.
The Marketplace MCR for the first quarter of 2026 was 84.0%. Within that result, approximately 450 basis points was due to prior year risk adjustment and continued program integrity initiatives by the Centers for Medicare and Medicaid Services. Excluding these items, the Marketplace MCR was approximately 79.5% and in line with the Company’s expectations.
General and Administrative Expense Ratio
The G&A ratio and the adjusted G&A ratio for the first quarter of 2026 were 7.2% and 6.9%, respectively, and reflect the timing of operating expenses.
Balance Sheet
Cash and investments at the parent company were approximately $213 million as of March 31, 2026, compared to $223 million as of December 31, 2025.
Days in claims payable at March 31, 2026, was 44, lower than typical due to the timing of payments at the end of the quarter.
Cash Flow
Operating cash flow for the three months ended March 31, 2026, was $1,082 million, compared to $190 million for the three months ended March 31, 2025. The increase in cash flow for the period year-over-year was driven mainly by the timing of government receivables and payables.
2026 Guidance
Premium revenue guidance for the full year is unchanged and expected to be approximately $42 billion, a decline of approximately 2% from the full year 2025.
The Company expects its full year 2026 GAAP earnings to be at least $1.90 per diluted share and reaffirms its full year 2026 adjusted earnings of at least $5.00 per diluted share. When the Company reports its second quarter of 2026 results, it expects to update full year 2026 guidance to reflect the first and second quarter results, which provide a time-tested base off of which to project the second half of 2026.
Conference Call
Management will host a conference call and webcast to discuss Molina Healthcare’s first quarter March 31, 2026 results, at 8:00 a.m. Eastern Time on Thursday, April 23, 2026. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 4352622. A telephonic replay of the conference call will be available through Thursday, April 30, 2026, by dialing (855) 669-9658 and entering confirmation number 6456388. A live audio broadcast of this conference call will be available on Molina Healthcare’s investor relations website, investors.molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.
About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This earnings release and the Company’s accompanying oral remarks contain forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding the Company’s 2026 guidance and long-term performance outlook, trends with respect to rates, utilization, and medical costs, including the timing thereof and the anticipated impact on the Company’s business, and our management’s plans and objectives for future operations and business strategy.
Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Report on Form 10-Q for the period ended March 31, 2026, to be filed with the SEC.
These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of April 22, 2026, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.
MOLINA HEALTHCARE, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended
March 31,
2026
2025
(In millions, except per-share amounts)
Revenue:
Premium revenue
$
10,172
$
10,628
Premium tax revenue
504
388
Investment income
98
108
Other revenue
22
23
Total revenue
10,796
11,147
Operating expenses:
Medical care costs
9,270
9,479
General and administrative expenses
779
774
Premium tax expenses
504
388
Depreciation and amortization
39
48
Impairment
93
—
Other
28
25
Total operating expenses
10,713
10,714
Operating income
83
433
Interest expense
54
43
Income before income tax expense
29
390
Income tax expense
15
92
Net income
$
14
$
298
Net income per share – Diluted
$
0.27
$
5.45
Diluted weighted average shares outstanding
51.0
54.8
MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
March 31,
December 31,
2026
2025
Unaudited
(Dollars in millions,
except per-share amounts)
ASSETS
Current assets:
Cash and cash equivalents
$
5,314
$
4,248
Investments
3,937
4,008
Receivables
3,420
3,533
Prepaid expenses and other current assets
655
655
Total current assets
13,326
12,444
Property, equipment, and capitalized software, net
300
301
Goodwill and intangible assets, net
2,092
2,195
Restricted investments
312
299
Deferred income taxes, net
215
178
Other assets
146
147
Total assets
$
16,391
$
15,564
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims and benefits payable
$
4,941
$
4,887
Amounts due government agencies
1,685
1,326
Accounts payable, accrued liabilities and other
1,161
1,093
Deferred revenue
401
66
Total current liabilities
8,188
7,372
Long-term debt
3,767
3,766
Finance lease liabilities
180
184
Other long-term liabilities
176
173
Total liabilities
12,311
11,495
Stockholders’ equity:
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 52 million shares at March 31, 2026, and 51 million at December 31, 2025
—
—
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding
—
—
Additional paid-in capital
471
452
Accumulated other comprehensive (loss) income
(7
)
15
Retained earnings
3,616
3,602
Total stockholders’ equity
4,080
4,069
Total liabilities and stockholders’ equity
$
16,391
$
15,564
MOLINA HEALTHCARE, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
March 31,
2026
2025
(In millions)
Operating activities:
Net income
$
14
$
298
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
39
48
Deferred income taxes
(30
)
13
Share-based compensation
33
27
Impairment
93
—
Other, net
—
2
Changes in operating assets and liabilities:
Receivables
113
(90
)
Prepaid expenses and other current assets
(86
)
(56
)
Medical claims and benefits payable
54
(81
)
Amounts due government agencies
359
(32
)
Accounts payable, accrued liabilities and other
79
(268
)
Deferred revenue
335
252
Income taxes
79
77
Net cash provided by operating activities
1,082
190
Investing activities:
Purchases of investments
(249
)
(189
)
Proceeds from sales and maturities of investments
295
331
Purchases of property, equipment, and capitalized software
(27
)
(22
)
Net cash paid in business combinations
—
(245
)
Other, net
(8
)
2
Net cash provided by (used in) investing activities
11
(123
)
Financing activities:
Proceeds from borrowings under credit facility and term loans
—
650
Common stock purchases
—
(500
)
Common stock withheld to settle employee tax obligations
(14
)
(36
)
Other, net
(6
)
33
Net cash (used in) provided by financing activities
(20
)
147
Net increase in cash, cash equivalents, and restricted cash and cash equivalents
1,073
214
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period
4,348
4,741
Cash, cash equivalents, and restricted cash and cash equivalents at end of period
$
5,421
$
4,955
MOLINA HEALTHCARE, INC.
UNAUDITED SEGMENT DATA
(Dollars in millions)
March 31,
December 31,
March 31,
2026
2025
2025
Ending Membership by Segment:
Medicaid
4,498,000
4,568,000
4,812,000
Medicare
229,000
262,000
260,000
Marketplace
305,000
655,000
662,000
Other
2,000
6,000
18,000
Total
5,034,000
5,491,000
5,752,000
Three Months Ended March 31,
2026
2025
Premium Revenue
Medical
Margin
MCR (1)
Premium Revenue
Medical
Margin
MCR (1)
Medicaid
$
7,927
$
631
92.0
%
$
8,130
$
791
90.3
%
Medicare
1,517
154
89.8
1,468
172
88.3
Marketplace
724
116
84.0
1,004
183
81.7
Other
4
1
88.4
26
3
87.7
Consolidated
$
10,172
$
902
91.1
%
$
10,628
$
1,149
89.2
%
(1) The MCR represents medical costs as a percentage of premium revenue.
MOLINA HEALTHCARE, INC.
CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)
The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:
Three Months Ended
March 31,
2026
2025
Unaudited
Medical claims and benefits payable, beginning balance
$
4,887
$
4,640
Components of medical care costs related to:
Current year
9,523
9,665
Prior year
(253
)
(186
)
Total medical care costs
9,270
9,479
Payments for medical care costs related to:
Current year
5,883
5,789
Prior year
3,628
3,684
Total paid
9,511
9,473
Acquired balances, net of post-acquisition adjustments
—
245
Change in non-risk and other payables
295
(87
)
Medical claims and benefits payable, ending balance
$
4,941
$
4,804
Days in Claims Payable (1)
44
46
___________
(1)
The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements.
MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES
(In millions, except per diluted share amounts)
The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.
Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, impairments, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.
Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.
Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.
Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.
Adjusted pre-tax margin represents adjusted income before income tax expense, divided by total revenue.
Three Months Ended March 31,
2026
2025
Amount
Per Diluted Share
Amount
Per Diluted Share
GAAP Net income
$
14
$
0.27
$
298
$
5.45
Adjustments:
Amortization of intangible assets
$
10
$
0.20
$
21
$
0.39
Acquisition-related expenses (1)
21
0.41
23
0.41
Impairment (2)
93
1.83
—
—
Other (3)
21
0.41
2
0.03
Subtotal, adjustments
145
2.85
46
0.83
Income tax effect
(39
)
(0.77
)
(11
)
(0.20
)
Adjustments, net of tax
106
2.08
35
0.63
Adjusted net income
$
120
$
2.35
$
333
$
6.08
__________
(1)
Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.
(2)
This impairment charge results from the Company’s decision to exit the Medicare Advantage Prescription Drug product for 2027 as that product does not align with the Company’s strategic shift to focus exclusively on dual eligible members in Medicare.
(3)
The three months ended March 31, 2026 primarily includes non-recurring termination benefits, and the three months ended March 31, 2025 includes non-recurring litigation costs.
MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)
2026 GUIDANCE
Amount
Per Diluted Share (2)
GAAP Net income
$
97
$
1.90
Adjustments:
Acquisition-related expenses
66
1.28
Amortization of intangible assets
36
0.71
Impairment
93
1.83
Other
21
0.41
Subtotal, adjustments
216
4.23
Income tax effect (1)
(57
)
(1.13
)
Adjustments, net of tax
159
3.10
Adjusted net income
$
256
$
5.00
__________
(1)
Income tax effect calculated at the statutory tax rate of approximately 26.8%.
(2)
Computations assume approximately 51.1 million diluted weighted average shares outstanding.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260422812502/en/
Investor Contact: Jeffrey Geyer, Jeffrey.Geyer @bbarrett49-3012
Media Contact: Caroline Zubieta, Caroline.Zubieta @DarkAura-1588
Original: Molina Healthcare Reports First Quarter 2026 Financial Results
US Market News
3月前
Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600March 6, 2026 6:39 PM
PR Newswire (US)
NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices:
NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE: ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on Monday, March 23, as part of the quarterly rebalance. The changes ensure that each index is more representative of its market–capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small–cap market space.Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective
DateIndex Name ActionCompany NameTickerGICS SectorMar 13, 2026S&P SmallCap 600AdditionNAPCO Security Technologies NSSC Information Technology Mar 13, 2026S&P SmallCap 600DeletionAlexander & Baldwin ALEX Real EstateMar 23, 2026S&P 100AdditionMicron TechnologyMU Information Technology Mar 23, 2026S&P 100AdditionLam ResearchLRCX Information Technology Mar 23, 2026S&P 100AdditionApplied MaterialsAMAT Information Technology Mar 23, 2026S&P 100AdditionGE VernovaGEV Industrials Mar 23, 2026S&P 100DeletionPayPal HoldingsPYPL Financials Mar 23, 2026S&P 100DeletionAmerican Intl GroupAIG Financials Mar 23, 2026S&P 100DeletionMetlifeMET Financials Mar 23, 2026S&P 100DeletionTargetTGT Consumer Staples Mar 23, 2026S&P 500AdditionVertiv HoldingsVRTIndustrialsMar 23, 2026S&P 500AdditionLumentum Holdings LITEInformation TechnologyMar 23, 2026S&P 500AdditionCoherentCOHRInformation TechnologyMar 23, 2026S&P 500AdditionEchoStarSATSCommunication ServicesMar 23, 2026S&P 500DeletionMatch Group MTCHCommunication ServicesMar 23, 2026S&P 500DeletionMolina HealthcareMOHHealth CareMar 23, 2026S&P 500DeletionLamb Weston Holdings LWConsumer StaplesMar 23, 2026S&P 500DeletionPaycom Software PAYCIndustrialsMar 23, 2026S&P MidCap 400AdditionSolstice Advanced Materials SOLSMaterialsMar 23, 2026S&P MidCap 400AdditionSiTime SITMInformation TechnologyMar 23, 2026S&P MidCap 400AdditionMoog MOG.AIndustrialsMar 23, 2026S&P MidCap 400AdditionInterDigital IDCCInformation TechnologyMar 23, 2026S&P MidCap 400AdditionVicor VICRIndustrialsMar 23, 2026S&P MidCap 400AdditionCareTrust REIT CTREReal EstateMar 23, 2026S&P MidCap 400DeletionLumentum Holdings LITEInformation TechnologyMar 23, 2026S&P MidCap 400DeletionCoherent COHRInformation TechnologyMar 23, 2026S&P MidCap 400DeletionEchoStar SATSCommunication ServicesMar 23, 2026S&P MidCap 400DeletionZoomInfo Technologies GTMCommunication ServicesMar 23, 2026S&P MidCap 400DeletionASGN ASGNInformation TechnologyMar 23, 2026S&P MidCap 400DeletionKemper KMPRFinancialsMar 23, 2026S&P SmallCap 600AdditionMatch Group MTCHCommunication ServicesMar 23, 2026S&P SmallCap 600AdditionMolina HealthcareMOHHealth CareMar 23, 2026S&P SmallCap 600AdditionLamb Weston Holdings LWConsumer StaplesMar 23, 2026S&P SmallCap 600AdditionPaycom Software PAYCIndustrialsMar 23, 2026S&P SmallCap 600AdditionVSE VSECIndustrialsMar 23, 2026S&P SmallCap 600AdditionArgan AGXIndustrialsMar 23, 2026S&P SmallCap 600AdditionRithm Capital RITMFinancialsMar 23, 2026S&P SmallCap 600AdditionLyft LYFTIndustrialsMar 23, 2026S&P SmallCap 600AdditionLaureate Education LAURConsumer DiscretionaryMar 23, 2026S&P SmallCap 600AdditionLife Time Group Holdings LTHConsumer DiscretionaryMar 23, 2026S&P SmallCap 600AdditionLife360 LIFInformation TechnologyMar 23, 2026S&P SmallCap 600AdditionSphere EntertainmentSPHRCommunication ServicesMar 23, 2026S&P SmallCap 600AdditionZoomInfo Technologies GTMCommunication ServicesMar 23, 2026S&P SmallCap 600AdditionASGNASGNInformation TechnologyMar 23, 2026S&P SmallCap 600AdditionKemper KMPRFinancialsMar 23, 2026S&P SmallCap 600DeletionSolstice Advanced Materials SOLSMaterialsMar 23, 2026S&P SmallCap 600DeletionSiTimeSITMInformation TechnologyMar 23, 2026S&P SmallCap 600DeletionMoog MOG.AIndustrialsMar 23, 2026S&P SmallCap 600DeletionInterDigital IDCCInformation TechnologyMar 23, 2026S&P SmallCap 600DeletionVicor CorpVICRIndustrialsMar 23, 2026S&P SmallCap 600DeletionCareTrust REIT CTREReal EstateMar 23, 2026S&P SmallCap 600DeletionDave & Buster's Entertainment PLAYConsumer DiscretionaryMar 23, 2026S&P SmallCap 600DeletionSunCoke Energy SXCMaterialsMar 23, 2026S&P SmallCap 600DeletionAH Realty Trust AHRTReal EstateMar 23, 2026S&P SmallCap 600DeletionSummit Hotel Properties INNReal EstateMar 23, 2026S&P SmallCap 600DeletionKKR Real Estate Finance Trust KREFFinancialsMar 23, 2026S&P SmallCap 600DeletionBloomin' Brands BLMNConsumer DiscretionaryMar 23, 2026S&P SmallCap 600DeletionMyriad Genetics MYGNHealth CareMar 23, 2026S&P SmallCap 600DeletionCars.com CARSCommunication ServicesMar 23, 2026S&P SmallCap 600DeletionANGI ANGICommunication ServicesABOUT S&P DOW JONES INDICESS&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/.FOR MORE INFORMATION:S&P Dow Jones Indices
index_services@spglobal.comMedia Inquiries
spdji.comms@spglobal.com
View original content:https://www.prnewswire.com/news-releases/vertiv-holdings-lumentum-holdings-coherent-and-echostar-set-to-join-sp-500-others-to-join-sp-100-sp-midcap-400-and-sp-smallcap-600-302707297.htmlSOURCE S&P Dow Jones Indices
Original: Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
iHub News
4月前
BottomBounce
1年前
Monksdream
2年前
whytestocks
6年前
TFMG
7年前
crudeoil24
8年前
stocktrademan
9年前
BaylorTradeKing
12年前
Penny Roger$
14年前
メールアドレスで登録
